预防性红细胞输血治疗状细胞疾病怀孕:增加治疗使用可能会改变结果
Sheinei Alan1, Deva Sharma2,3, Lydia H Pecker4,5
1INOVA Adult Sickle Cell Program, Inova Schar Cancer Institute, Fairfax, Virginia.
Current opinion in hematology
|August 23, 2024
概括
输血治疗显著改善了患有状细胞疾病 (SCD) 的孕妇的结果,降低了产妇和胎儿死亡率. 由于其已证明的好处和低风险,建议更广泛地使用这些输血.
科学领域:
- 血液学 血液学 血液学
- 产科 产科 产科 产科 产科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
背景情况:
- 患有状细胞疾病 (SCD) 个体的怀孕具有巨大的孕产妇和胎儿死亡率和发病率风险.
- 输血疗法是研究最多的干预措施,而氧尿素一般是避免由于产性问题.
- 红细胞输血的获取和利用在高资源和低资源环境之间有很大差异.
研究的目的:
- 审查预防性输血治疗对患有SCD的孕妇的益处和风险.
- 评估输血对SCD怀孕中母亲和胎儿结果的影响.
- 倡导在这个高风险人群中增加慢性输血治疗的使用.
主要方法:
- 随机对照试验和元分析的分析,证明了输血治疗的疗效.
- 对下游益处的证据的审查,包括贫血改善和减少住院治疗.
- 对输血风险的评估,如与免疫接种,以及缓解策略.
主要成果:
- 输血治疗显著减少了孕产妇和胎儿死亡,痛苦的危机,血栓形成和急性呼吸衰竭.
- 潜在的益处包括改善母亲贫血,减少阿片类药物暴露,避免住院相关并发症.
- 同免疫是公认的风险,但存在有效的缓解策略,导致美国血液学会的低风险分类.
结论:
- 慢性输血治疗SCD怀孕是由于其低风险分类和深刻的潜在益处表明.
- 缺乏替代疗法和持续不良的妊娠结果强调需要更广泛地采用输血.
- 实施预防性输血对于改变SCD患者的妊娠结果至关重要.
更多相关视频
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
19.4K
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
9.8K
相关概念视频
Rh Blood Group
1.4K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.4K
Bone Marrow Sampling and Transplants
316
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
316
Factors Affecting Erythropoiesis
3.2K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.2K
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Disorders of Erythrocytes
907
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
907
